🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for transformative findings that clarify how the body's defense network attacks dangerous pathogens while sparing the healthy tissues.

Three renowned scientists—from Japan Prof. Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this accolade.

Their research uncovered specialized "security guards" within the immune system that eliminate malfunctioning immune cells capable of harming the body.

These discoveries are now paving the way for innovative therapies for autoimmune diseases and malignancies.

The winners will divide a monetary award worth 11 million SEK.

Crucial Findings

"The research has been essential for comprehending how the immune system functions and the reason we don't all develop severe autoimmune diseases," stated the head of the award panel.

The trio's research explain a fundamental question: In what way does the immune system protect us from countless invaders while leaving our healthy cells intact?

Our immune system uses white blood cells that scan for indicators of infection, even pathogens and germs it has not met before.

Such defenders employ sensors—known as receptors—that are produced randomly in a vast number of variations.

This provides the immune system the capacity to combat a broad range of threats, but the randomness of the process inevitably creates immune cells that can attack the body.

Security Guards of the Immune System

Scientists previously knew that some of these harmful defense cells were eliminated in the thymus—where immune cells develop.

This year's award recognizes the identification of regulatory T-cells—known as the immune system's "peacekeepers"—which patrol the body to disarm other defenders that assault the healthy cells.

It is known that this mechanism malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "These findings have established a new field of research and spurred the creation of innovative treatments, for example for cancer and autoimmune diseases."

Regarding cancer, T-regs block the body from fighting the tumor, so research are aimed at lowering their quantity.

For autoimmune diseases, experiments are exploring boosting regulatory T-cells so the organism is not being harmed. A similar method could also be useful in reducing the chances of organ transplant rejection.

Innovative Studies

Professor Sakaguchi, from a Japanese institution, conducted tests on rodents that had their thymus extracted, causing self-attack conditions.

The researcher showed that injecting immune cells from healthy animals could prevent the disease—implying there was a system for blocking immune cells from attacking the host.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at a biotech firm in a California city, were investigating an inherited autoimmune disease in mice and people that resulted in the identification of a gene vital for the way T-regs function.

"The groundbreaking work has uncovered how the immune system is kept in check by T-reg cells, stopping it from mistakenly targeting the body's own tissues," commented a prominent biological science specialist.

"The work is a remarkable illustration of how fundamental physiological research can have far-reaching implications for public health."